C.M. Bidwell & Associates’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-62
Closed -$596 511
2025
Q4
$596 Hold
62
﹤0.01% 461
2025
Q3
$756 Hold
62
﹤0.01% 444
2025
Q2
$495 Buy
+62
New +$435 ﹤0.01% 423
2023
Q1
Sell
-50
Closed -$2.11K 549
2022
Q4
$2.11K Hold
50
﹤0.01% 447
2022
Q3
$2K Sell
50
-15
-23% -$625 ﹤0.01% 427
2022
Q2
$3K Hold
65
﹤0.01% 414
2022
Q1
$3K Hold
65
﹤0.01% 453
2021
Q4
$3K Buy
+65
New +$2.89K ﹤0.01% 495
2021
Q1
Sell
-2,220
Closed -$121K 538
2020
Q4
$121K Sell
2,220
-729
-25% -$38.4K 0.1% 198
2020
Q3
$148K Buy
2,949
+949
+47% +$45K 0.14% 156
2020
Q2
$76K Buy
+2,000
New +$64.3K 0.07% 225
2018
Q4
Sell
-6,070
Closed -$500K 448
2018
Q3
$500K Buy
+6,070
New +$482K 0.47% 58
2017
Q1
Sell
-67,690
Closed -$3.23M 276
2016
Q4
$3.23M Sell
67,690
-5,300
-7% -$297K 0.76% 68
2016
Q3
$4.73M Buy
72,990
+51,670
+242% +$2.91M 1.13% 15
2016
Q2
$985K Buy
+21,320
New +$859K 0.24% 88
2015
Q4
Sell
-6,450
Closed -$266K 266
2015
Q3
$266K Hold
6,450
0.07% 135
2015
Q2
$304K Buy
+6,450
New +$349K 0.07% 133
2013
Q3
Sell
-48,280
Closed -$2.95M 249
2013
Q2
$2.95M Buy
+48,280
New +$2.68M 0.87% 56

Other funds holding NUS

C.M. Bidwell & Associates's NUS Position: Q1 2026 in Review

C.M. Bidwell & Associates sold out of Nu Skin (NUS) in Q1 2026, closing a stake of 62 shares — an estimated $596 sold.

C.M. Bidwell & Associates first reported a position in NUS in Q2 2013 and held it in 18 quarters. The position peaked at $4.73M in Q3 2016. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.

  • C.M. Bidwell & Associates reported no remaining Nu Skin position as of Q1 2026 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 62 Nu Skin shares in Q1 2026, an estimated $596.
  • C.M. Bidwell & Associates first reported a position in Nu Skin in Q2 2013 and held it in 18 quarters.
  • C.M. Bidwell & Associates's Nu Skin position peaked at $4.73M in Q3 2016.
  • 178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.